Navigation Links
Promidian Survey Finds Growing Support for Patient-Centered Medical Home
Date:3/29/2011

BERKELEY HEIGHTS, N.J., March 29, 2011 /PRNewswire/ -- Promidian, a management consulting firm focused on the pharmaceutical and biotechnology industries, today announced top-line survey findings about the increasing interest in the patient-centered medical home (PCMH), a patient-centric delivery-of-care model that is rapidly gaining nationwide attention for its potential to improve quality and access to health care—while reducing costs.

The Promidian PCMH survey was completed in March 2011 and included a nationwide mix of 181 stakeholders, including physicians, medical directors, nurses, and administrators and executives from medical group practices, health plans, pharmaceutical companies, and employer groups. The survey found that

  • Patient engagement in care, access to care, and a team approach to care are viewed as the most important components of a PCMH;
  • Priority disease states highlighted by PCMHs include diabetes, cardiovascular disease, asthma, obesity, and stroke;
  • Medication adherence is viewed as extremely important to the success of a PCMH, and PCMHs are considering and evaluating a number of tactics to improve medication adherence;
  • The vast majority of PCMH representatives are interested in receiving targeted resources to help achieve or maintain accreditation (eg, programs, tools, and training).

"Our survey identified a number of key priorities and challenges for PCMHs, as well as highlighted opportunities for pharmaceutical companies to positively influence and support the evolution of this innovative care delivery model," said Kevin Barnett, Executive Vice President and Managing Director for Promidian.

The complete results of the survey will be available at the Promidian exhibit booth at the Patient-Centered Primary Care Collaborative (PCPCC) Conference on March 29-31, at the Ronald Reagan Building, International Trade Center in Washington, DC.

About Promidian

Promidian is a management consulting firm that is focused on the pharmaceutical, biotechnology, and life sciences industries. We combine deep industry and functional area knowledge with specialized expertise in market assessment, analytics, and strategy development—to assist life sciences executives in addressing their most pressing business challenges.

For more information on the PCMH survey or to learn more about Promidian's service offerings, please contact Kevin Barnett, Executive Vice President, at kbarnett@promidianconsulting.com, or visit our Web site at www.promidianconsulting.com.

Promidian is a company of the Access Group (www.theaccessgroup.com).


'/>"/>
SOURCE Promidian
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Survey Emphasizes Value of Biopharmaceutical Company Engagement With Healthcare Providers
2. New Nationwide Survey Identifies Need for Increased Dialogue Between Gastroesophageal Reflux Disease or Frequent Heartburn Sufferers and Health Care Providers
3. National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis
4. Survey Sampling International Names Chris DeAngelis to Head New SSI Health
5. Reportlinker Adds Global Physician Survey on Stents, Stent-Grafts and Vulnerable Plaque Treatment 2011
6. Thats Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
7. Survey Finds Patients Oppose Prescription Mandate for OTC Medicines Containing Pseudoephedrine
8. Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available
9. On Average, 55 Percent of Surveyed U.S. Asthma Patients Say They Are Likely to Request a Switch to a Drug With Efficacy Comparable to Their Current Medication but Which is Dosed Just Once a Day
10. Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey
11. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , Feb. 17, 2017  Perrigo Company plc (NYSE, TASE: PRGO) ... Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide ... Hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), ... symptomatic relief of cough in adults and children 6 years ... ending January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and Rest ... through 2022. Also, a six-year historic analysis is provided for these markets. ...
(Date:2/17/2017)... MIAMI , Feb. 17, 2017  In partnership ... Friends for Good Health , The Jack ... container filled with millions of dollars, worth of medicine ... Haiti . IHI is a non-profit dedicated to ... IHI is extremely active in Haiti ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... February 19, 2017 , ... "At your fingertips" electronic ... MEDfx and the Delaware Health Information Network (DHIN) have partnered to improve connectivity ... state-wide health information exchange, DHIN stores and shares real-time health data for more ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews ... and other Butler products. Ken was impressed with the safety and reliability of ... the product on his show. This endorsement by Ken Matthews can be heard ...
(Date:2/18/2017)... ... February 18, 2017 , ... A ... information and contact points to easily connect elderly veterans of America's armed forces ... elder-care funding. It also conveys material on this year's increase in the Veterans ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network offers physicians ... controlled and non-controlled substances plus the ability to manage orders on their desktop ... now accept electronic prescriptions, according to the Office of the National Coordinator of ...
(Date:2/17/2017)... Church, VA (PRWEB) , ... February 17, 2017 ... ... Implementing the Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, ... , Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? ...
Breaking Medicine News(10 mins):